DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Clopidogrel Bisulfate is a drug marketed by Accord Hlthcare, Acme Labs, Actavis Totowa, Amneal Pharms, Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Cadila, Celltrion, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Graviti Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, Polygen Pharms, Prinston Inc, Sciegen Pharms Inc, Sun Pharm, Sun Pharm Industries, Teva, and Torrent Pharms Ltd. and is included in twenty-two NDAs.
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
A generic version of CLOPIDOGREL BISULFATE was approved as clopidogrel bisulfate by DR REDDYS LABS INC on January 14th, 2008.
Summary for CLOPIDOGREL BISULFATE
Recent Clinical Trials for CLOPIDOGREL BISULFATE
Identify potential brand extensions & 505(b)(2) entrants
|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||N/A|
|The First Affiliated Hospital with Nanjing Medical University||Phase 4|
|CKD Pharmaceutical Limited||Phase 4|